| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |